Poly Medicure Limited Approves FY26 Audited Results and Recommends Dividend of Rs. 3.5 Per Share
Poly Medicure Limited announced that its Board of Directors meeting, held on May 25, 2026, approved the Audited Financial Results for the fourth quarter and the financial year ended March 31, 2026. The board also recommended a dividend of Rs. 3.5 per Equity Share (70% of Rs. 5) for the Financial Year 2025-26, pending shareholder approval.During the board meeting, the company also finalized the re-appointment of internal auditors for the Financial Year 2026-27. M/s PricewaterhouseCoopers Services LLP and M/s Oswal Sunil & Co. Chartered Accountants were re-appointed for this role.
Financial Performance Overview
The company released comprehensive financial results detailing performance for the period ended March 31, 2026. The consolidated financial statements reveal key figures from the audited results for the preceding years and quarters.Key figures for the Consolidated Standalone and Group operations include:
| Metric | Year Ended 31.03.2026 (Audited) | Year Ended 31.03.2025 (Audited) |
|---|---|---|
| Total Assets (Lacs) | 1,94,173.32 | 3,19,245.22 |
| Total Equity (Lacs) | 3,14,924.32 | 2,76,565.78 |
| Total Comprehensive Income (Lacs) | 33,720.25 | 36,865.64 |
The financial results included detailed performance data for the year ended 31.03.2026:
| Metric (Lacs) | Year Ended 31.03.2026 | Year Ended 31.03.2025 |
|---|---|---|
| Consolidated Total Revenue | 1,99,534.14 | 12,008.22 |
| Consolidated Total Equity Attributable to Shareholders | 3,05,271.24 | 2,69,355.60 |
| Consolidated Net Profit (Attributable to Equity Holders) | 9,197.53 | 7,093.02 |
Auditor Appointments
The Board approved the re-appointment of the following firms as Internal Auditors for the Financial Year 2026-27:- M/s PricewaterhouseCoopers Services LLP
- M/s Oswal Sunil & Co. Chartered Accountants
The company confirmed that the statutory auditors, M/s Doogar & Associates, issued an unmodified audit opinion on the Audited Standalone and Consolidated Financial Results for the period ended March 31, 2026.
POLYMED Stock Price Movement
Shares of Poly Medicure Limited on Monday slipped by 4.89% to settle at ₹1547.2. The equity saw 167,446 shares traded, carving out an intraday range between ₹1515 and ₹1634.2.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.